Manar Jbara
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Manar
Contact Manar, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
Pulmonary Embolism as a Cardiovascular Emergency: Optimizing Early Diagnosis and Management in the Emergency Department
Choose an area of interest and we will send you notifications of new preprints at your preferred frequency.
Abciximab-induced delayed profound thrombocytopaenia
Abciximab, the first approved glycoprotein (GP IIb/IIIa) inhibitor, is being widely used during acute coronary syndromes and offers the promising approach to antithrombotic therapy. We present a case of a young woman who initially received abciximab infusion for undergoing percutaneous coronary intervention of left anterior descending artery and was eventually diagnosed with abciximab-induced delayed thrombocytopaenia.
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Manar
Contact Manar, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack